The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B. (Q39542236)
Jump to navigation
Jump to search
scientific article published on 10 March 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B. |
scientific article published on 10 March 2008 |
Statements
1 reference
The PPARgamma agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B. (English)
1 reference
L P Quinn
1 reference
B Crook
1 reference
M E Hows
1 reference
M Vidgeon-Hart
1 reference
H Chapman
1 reference
N Upton
1 reference
A D Medhurst
1 reference
D J Virley
1 reference
10 March 2008
1 reference
1 reference
154
1 reference
1
1 reference
226-233
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference